Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes

Digestive Diseases and Sciences

Volumn 61, Issue 10, 2016, Pages 3007-3015

  Girotra, Mohit ^a,b   Garg, Shashank ^a,c   Anand, Rohit ^a   Song, Yang ^a,d   Dutta, Sudhir K ^a,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d Institute for Genome Sciences   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Clostridium difficile; Colonic; Efficacy; Elderly; Fecal microbiota transplantation; Geriatric; Jejunal; Outcomes; Safety

Indexed keywords

BACTERIAL TOXIN; CLOSTRIDIUM DIFFICILE LETHAL TOXIN B; ENTEROTOXIN; RNA 16S;

ABDOMINAL PAIN; ADVERSE OUTCOME; AGED; ARTICLE; BLOATING; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FEVER; FIRMICUTES; FOLLOW UP; GENOME ANALYSIS; GERIATRIC PATIENT; HUMAN; INFECTION; LEUKOCYTOSIS; LONG TERM SURVIVAL; MALE; MICROBIAL DIVERSITY; OBSERVATIONAL STUDY; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEOBACTERIA; RECURRENT DISEASE; RECURRENT INFECTION; THERAPY EFFECT; TREATMENT OUTCOME; VERY ELDERLY; AGE; CHEMISTRY; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; GENETICS; INTESTINE FLORA; LONGITUDINAL STUDY; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; SEQUENCE ANALYSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; FIRMICUTES; GASTROINTESTINAL MICROBIOME; HUMANS; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; PROTEOBACTERIA; RECURRENCE; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, RNA; TREATMENT OUTCOME;

EID: 84979502176     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-016-4229-8     Document Type: Article

References (33)

1. Lessa FC, Yi Mu, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–834.
2. Garg S, Mirza YR, Girotra M, et al. Epidemiology of Clostridium difficile-associated disease (CDAD): a shift from hospital-acquired infection to long-term care facility-based infection. Dig Dis Sci. 2013;58:3407–3412.
3. Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107:89–95.
4. Rodriguez C, Korsak N, Taminiau B, et al. Clostridium difficile infection in elderly nursing home residents. Anaerobe. 2014;30:184–187.
5. Zapata HJ, Quagliarello VJ. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc. 2015;63:776–781.
6. Minino AM, Xu J, Kochanek KD. National Vital Statistics Reports. Vol 59, number 2. Centers for Disease Control and Prevention (CDC). http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_02.pdf.
7. Drekonja D, Reich J, Gezahegn S, et al. Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med. 2015;162:630–638.
8. Dutta SK, Girotra M, Garg S, et al. Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2014;12:1572–1576.
9. Walia R, Garg S, Song Y, et al. Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome. J Pediatr Gastroenterol Nutr. 2014;59:565–570.
10. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011;108:4680–4687.
11. Fadrosh DW, Ma B, Gajer P, et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome. 2014;2:6.
12. Song Y, Garg S, Girotra M, et al. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS ONE. 2013;8:e81330.
13. Masella AP, Bartram AK, Truszkowski JM, et al. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics. 2012;13:31.
14. Nelson MC, Morrison HG, Benjamino J, et al. Analysis, optimization and verification of Illumina-generated 16 s rrna gene amplicon surveys. PLoS ONE. 2014;9:e94249.
15. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–336.
16. White JR, Nagarajan N, Pop M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol. 2009;5:e1000352.
17. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108:500–508.
18. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994–1002.
19. Emanuelsson F, Claesson BE, Ljungstr ML, et al. Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients. Scand J Infect Dis. 2014;46:89–97.
20. Rubin TA, Gessert CE, Aas J, et al. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anaerobe. 2013;19:22–26.
21. Mattila E, Uusitalo-Seppala R, Wuorela M, et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology. 2012;142:490–496.
22. Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term followup of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079–1087.
23. Kim KA, Gu W, Lee IA, et al. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE. 2012;7:e47713.
24. Zapata HJ, Quagliarello VJ. Microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc. 2015;63:776–781.
25. Magrone T, Jirillo E. The interaction between gut microbiota and age-related changes in immune function and inflammation. Immun Ageing. 2013;10:31.
26. Drago L, Toscano M, Rodighiero V, et al. Cultivable and pyrosequenced fecal microflora in centenarians and young subjects. J Clin Gastroenterol. 2012;46:S81–S84.
27. Biagi E, Candela M, Turroni S, et al. Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res. 2013;69:11–20.
28. Shahinas D, Silverman M, Sittler T, et al. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. mBio. 2012;3:e00338-12. doi:10.1128/mBio.00338-12.
29. Weingarden A, González A, Vázquez-Baeza Y, et al. Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome. 2015;3:10.
30. Hamilton MJ, Weingarden AR, Unno T, et al. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes. 2013;4:125–135.
31. Wang W, Chen L, Zhou R, et al. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol. 2014;52:398–406.
32. Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63:1275–1283.
33. Antharam VC, Li EC, Ishmael A, et al. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol. 2013;51:2884–2892.